Targeting multiplicity: the key factor for anti-cancer nanoparticles.
Gary-Bobo M, Vaillant O, Maynadier M, Basile I, Gallud A, El Cheikh K, Bouffard E, Morère A, Rébillard X, Puche P, Nirdé P, Garcia M.
Gary-Bobo M, et al. Among authors: basile i.
Curr Med Chem. 2013;20(15):1946-55. doi: 10.2174/0929867311320150002.
Curr Med Chem. 2013.
PMID: 23409718
Review.